Dietary Supplement Listing Act of 2024

The Dietary Supplement Listing Act of 2024 requires manufacturers, packers, and distributors of dietary supplements sold in the U.S. to submit detailed product information to the Food and Drug Administration (FDA) by specific deadlines. Existing supplements on the market by January 1, 2025, must be listed within 18 months of enactment, while new products require listing at the time of sale. The required details include ingredients, label content, claims, allergen statements, and product form, with the FDA creating a public online database of this information within two years (excluding certain confidential data). The law does not require pre-market approval but mandates these listings and updates for changes or discontinuation.